Columbia Sportswear Company (COLM) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
30 Jul, 2026Executive summary
Net sales grew 2% year-over-year to $614–$614.4 million, driven by strong international performance, while U.S. sales declined 4% amid soft DTC traffic and higher promotional activity.
Gross margin expanded 920 bps to 58.3%, primarily due to a $78 million IEEPA tariff refund, with $60–$62 million recognized in earnings.
Operating margin improved to 5.0% from a prior-year loss, with diluted EPS rising to $0.52 from a $0.19 loss per share.
The ACCELERATE strategy is showing early signs of success, especially in Columbia brand footwear, with improved brand awareness and new customer acquisition.
Inventory declined 6% year-over-year, and the company exited the quarter with $624.6–$625 million in cash and no debt.
Financial highlights
Net income was $26.6 million, up from a loss of $10.2 million in the prior year.
SG&A expenses increased 2% year-over-year, mainly due to higher DTC expenses and new stores, partially offset by lower personnel and technology costs.
Free cash flow for the first half was $11.6 million, compared to negative $92.9 million in the prior year.
Capital expenditures for the first half were $25.8 million, down from $30.0 million last year.
Operating cash flow for the first half was $37.5 million, up from a $62.9 million outflow in 2025.
Outlook and guidance
Full-year 2026 net sales expected at $3.43–$3.50 billion, up 1–3% year-over-year.
Gross margin guidance raised to 52.1–52.3%, reflecting tariff refund benefits.
Operating margin outlook increased to 8.5–9.3%; diluted EPS guidance raised to $4.45–$4.90.
Q3 2026 net sales expected to be flat to down 1.5% year-over-year, with EPS of $1.15–$1.35.
Tariff refunds to provide a $15 million benefit in H2, offset by factory accommodations; Q3 margin headwind, Q4 margin tailwind expected.
Latest events from Columbia Sportswear Company
- Q2 sales dropped 8% as U.S. weakness offset gains abroad, but cash and inventory improved.COLM
Q2 20248 Jul 2026 - Q4 margin gains and international growth contrast with full-year decline; 2025 outlook positive.COLM
Q4 20248 Jul 2026 - Q1 sales up 1%, outlook withdrawn amid tariff uncertainty; strong cash, share buybacks.COLM
Q1 20258 Jul 2026 - Board elections, key proposals, and 2025 results highlighted modest growth and strategic shifts.COLM
AGM 202615 Jun 2026 - Q1 2026 sales held steady at $779M as innovation and digital growth drive long-term strategy.COLM
Investor presentation15 May 2026 - Flat Q1 sales, improved FY2026 outlook, and strong international growth offset U.S. softness.COLM
Q1 20267 May 2026 - 2025 delivered modest sales growth, strong global expansion, and robust financial discipline.COLM
Investor presentation30 Apr 2026 - 2026 annual meeting covers director elections, pay, stock plan, and proxy access, with Board opposition to proxy access.COLM
Proxy filing24 Apr 2026 - Key votes include board elections, auditor ratification, and a proxy access proposal.COLM
Proxy filing24 Apr 2026